RACS does not support the Application by Honeysuckle Healthcare Pty Ltd and other applicants for authorisation to form and operate a buying group for a period of ten years. The reason being, the Application is  

  • ultimately uncompetitive, detrimental to our patients, and
  • goes against our blended healthcare system with the potential of creating a more litigious climate

In our submission RACS focuses on what we believe are the key elements of the Application which will dictate the business dealings of equal partners Honeysuckle Health and nib, and American based Cigna Corporation. “Managed agreements” in the Application under 2.32 is ‘managed care’ and it is a healthcare system which differs from Australia’s blended system designed for our demographic.